Ligand validation:3SYS

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3SYS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
3SYS_C8E_B_405	30%	90%	0.163	0.955	0.25	0.37	-	-	0	29%	0.2857
3SYS_C8E_A_405	28%	86%	0.125	0.818	0.37	0.34	-	-	0	76%	0.7619
3SYS_C8E_B_402	25%	86%	0.127	0.878	0.26	0.45	-	-	0	33%	0.3333
3SYS_C8E_A_410	24%	82%	0.116	0.874	0.44	0.35	-	-	0	29%	0.2857
3SYS_C8E_B_407	24%	92%	0.13	0.869	0.36	0.17	-	-	1	38%	0.381
3SYS_C8E_A_403	23%	91%	0.14	0.862	0.38	0.19	-	-	0	43%	0.4286
3SYS_C8E_A_404	21%	82%	0.159	0.829	0.37	0.43	-	-	0	67%	0.6667
3SYS_C8E_B_414	20%	74%	0.179	0.924	0.35	0.63	-	-	0	19%	19.05
3SYS_C8E_A_406	18%	86%	0.153	0.879	0.34	0.38	-	-	0	24%	0.2381
3SYS_C8E_A_400	17%	83%	0.186	0.87	0.22	0.56	-	-	1	43%	0.4286
3SYS_C8E_B_404	17%	77%	0.174	0.839	0.3	0.59	-	-	1	52%	0.5238
3SYS_C8E_A_409	17%	88%	0.138	0.814	0.45	0.23	-	-	0	43%	0.4286
3SYS_C8E_B_403	16%	88%	0.195	0.905	0.26	0.41	-	-	0	24%	0.2381
3SYS_C8E_A_407	15%	88%	0.128	0.785	0.25	0.42	-	-	1	43%	0.4286
3SYS_C8E_B_411	14%	88%	0.15	0.829	0.28	0.39	-	-	0	29%	0.2857
3SYS_C8E_A_402	13%	88%	0.143	0.804	0.28	0.39	-	-	4	29%	0.2857
3SYS_C8E_A_401	12%	87%	0.133	0.777	0.27	0.43	-	-	0	33%	0.3333
3SYS_C8E_A_412	11%	83%	0.154	0.769	0.25	0.52	-	-	7	43%	0.4286
3SYS_C8E_B_406	10%	85%	0.183	0.766	0.46	0.29	-	-	0	57%	0.5714
3SYS_C8E_A_411	9%	86%	0.171	0.757	0.46	0.26	-	-	0	43%	0.4286
3SYS_C8E_B_410	8%	81%	0.222	0.771	0.33	0.48	-	-	2	52%	0.5238
3SYS_C8E_B_409	7%	89%	0.201	0.75	0.4	0.24	-	-	0	48%	0.4762
3SYS_C8E_B_408	7%	88%	0.184	0.747	0.28	0.38	-	-	0	33%	0.3333
3SYS_C8E_A_408	5%	88%	0.223	0.749	0.38	0.3	-	-	0	33%	0.3333
3SYS_C8E_B_412	4%	87%	0.248	0.698	0.38	0.32	-	-	0	67%	0.6667
3SYS_C8E_A_413	3%	88%	0.273	0.677	0.47	0.2	-	-	7	71%	0.7143
3SYS_C8E_B_416	3%	88%	0.178	0.652	0.29	0.37	-	-	0	24%	0.2381
3SYS_C8E_B_415	3%	86%	0.31	0.756	0.27	0.45	-	-	1	33%	0.3333
3SYS_C8E_B_413	2%	90%	0.402	0.789	0.33	0.28	-	-	6	24%	0.2381
2QTK_C8E_A_394	13%	44%	0.255	0.869	0.69	1.48	-	2	1	62%	0.619
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	86%	0.8571

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

3SYS

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3SYS designated by the RCSB